Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1

Interventions

pembrolizumab 553Specimen Handling 466Carboplatin 442Magnetic Resonance Spectroscopy 430Cyclophosphamide 415Cisplatin 397Radiotherapy 312Gemcitabine 309Bevacizumab 309Paclitaxel 295Biopsy 259Drug Therapy 249Capecitabine 242fludarabine 239Oxaliplatin 239Nivolumab 225venetoclax 219Injections 213Docetaxel 205Fluorouracil 203Dexamethasone 186Radiosurgery 172Rituximab 158Pemetrexed 153Standard of Care 147durvalumab 143Leucovorin 139atezolizumab 138toripalimab 134tislelizumab 134

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Interventional × Laryngectomy × Clear all
NCT07392580 2026-06-01

Intralesional Chemotherapy (IC): Cisplatin + Epinephrine

University of Miami

Phase 2 Recruiting
20 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡